Key terms
About CDMO
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CDMO news
Yesterday
9:05am ET
Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)
Yesterday
6:13am ET
Avid Bioservices Q3 Financial Results Conference Call Announcement
Apr 24
5:32pm ET
Avid Bioservices still sees FY24 revenue $137M-$147M, consensus $138.66M
Apr 24
5:31pm ET
Avid Bioservices reports Q3 EPS (9c), consensus (5c)
Apr 16
8:40am ET
Analysts’ Top Healthcare Picks: Avid Bioservices (CDMO), LifeMD (LFMD)
Apr 01
8:36am ET
Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)
Mar 27
4:55am ET
Avid Bioservices management to meet with Craig Hallum
Mar 25
7:46am ET
Avid Bioservices management to meet with Craig Hallum
Mar 20
7:16am ET
Avid Bioservices announces receipt of deficiency notice from Nasdaq
Mar 12
4:58pm ET
Avid Bioservices to delay 10-Q filing, must restate Q3 financials
Mar 11
7:52am ET
Avid Bioservices price target lowered to $12 from $15 at Stephens
Mar 07
8:46pm ET
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Mar 07
8:40am ET
Analysts Are Bullish on Top Healthcare Stocks: Alimera (ALIM), Avid Bioservices (CDMO)
Mar 06
5:14pm ET
Avid Bioservices sees Q3 revenue $33.8M, consensus $41.6M
Mar 06
4:33pm ET
Avid Bioservices announces $160M convertible senior notes offering
Feb 29
9:30am ET
Analysts’ Top Healthcare Picks: Trulieve Cannabis (TCNNF), Avid Bioservices (CDMO)
Jan 29
8:50am ET
Analysts Are Bullish on Top Healthcare Stocks: Science 37 (SNCE), Avid Bioservices (CDMO)
Apr 14
11:16am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
Apr 06
1:17pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
Apr 03
2:20pm ET
SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Mar 29
11:01am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
Mar 25
7:00pm ET
SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Mar 15
1:04pm ET
Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities - Hagens Berman
Mar 12
7:06am ET
SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
CDMO Financials
Key terms
Ad Feedback
CDMO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CDMO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
